MIR99AHG/miR-204-5p/TXNIP/Nrf2/ARE Signaling Pathway Decreases Glioblastoma Temozolomide Sensitivity

LncRNA HOXA-AS2 promotes glioblastoma carcinogenesis by targeting miR-885-5p/RBBP4 axis

(2021) Jixin Shou et al.   Cancer Cell International

MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma

(2021) Chencheng Han et al.   Cell Death & Disease

LncRNA SNHG12 contributes proliferation, invasion and epithelial-mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b

(2020) Wei Cao et al.   BIOSCIENCE REPORTS

Glioblastoma under siege of Therapeutics and Research: “Advancements and Future Targets”

(2020) Vishal Chavda et al.   CURRENT DRUG METABOLISM

Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer

(2020) Ming Xie et al.   CELL BIOLOGY INTERNATIONAL

miR‑204‑5p promotes apoptosis and inhibits migration of gastric cancer cells by targeting HER‑2

(2020) Shu Yang et al.   Molecular Medicine Reports

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

(2020) Alja Zottel et al.   Cancers

HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer

(2020) Shaozheng Chen et al.   BMC CANCER

Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis

(2020) Qingyang Meng et al.   Cancer Cell International

lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma

(2020) Guodong Tang et al.   CANCER LETTERS

circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression

(2020) Yingkuan Liang et al.   Molecular Therapy-Nucleic Acids

Glioblastoma vs temozolomide: can the red queen race be won?

(2019) Anjali Arora et al.   CANCER BIOLOGY & THERAPY

Long Non-Coding RNA in the Pathogenesis of Cancers

(2019) Chi et al.   Cells

Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma

(2019) Bowen Yang et al.   Frontiers in Oncology

CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway

(2019) Qiong Chen et al.   CANCER LETTERS

Silencing of TXNIP Alleviated Oxidative Stress Injury by Regulating MAPK–Nrf2 Axis in Ischemic Stroke

(2019) Yu Tian et al.   NEUROCHEMICAL RESEARCH

miR‑204‑5p and miR‑3065‑5p exert antitumor effects on melanoma cells

(2018) Nadezhda Palkina et al.   Oncology Letters

miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression

(2018) Yi Chu et al.   FEBS Open Bio

miR‑204‑5p inhibits the occurrence and development of osteoarthritis by targeting Runx2

(2018) Jiaqing Cao et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

(2018) Shabierjiang JIAPAER et al.   NEUROLOGIA MEDICO-CHIRURGICA

LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1

(2018) Chao Liang et al.   PATHOLOGY RESEARCH AND PRACTICE

The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment

(2017) Violetta Krajka-Kuźniak et al.   Pharmacological Reports

A comprehensive profile of recurrent glioblastoma

(2016) B Campos et al.   ONCOGENE

Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion

(2015) Zhiqiang Xia et al.   PLoS One

LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia

(2014) Stephan Emmrich et al.   Molecular Cancer

Glioblastoma and Other Malignant Gliomas

(2013) Antonio Omuro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Definition of Primary and Secondary Glioblastoma

(2012) H. Ohgaki et al.   CLINICAL CANCER RESEARCH

Standard Therapy for Glioblastoma— A Review of Where We Are

(2010) Ryo NISHIKAWA   NEUROLOGIA MEDICO-CHIRURGICA